Fast Five Quiz: Urothelial Carcinoma

Kyle A. Richards, MD


August 13, 2020

Analysis of data from the National Cancer Institute's SEER program revealed that most patients with urothelial carcinoma had a localized tumor (76.7%). The NCCN treatment guidelines recommend complete TURBT as the primary treatment for patients with non–muscle-invasive bladder cancer. Single-dose intravesical chemotherapy within 24 hours (ideally within 6 hours) of TURBT is recommended and may reduce the rate of recurrence. In addition, imaging of the upper tract collecting system is recommended, if not previously performed.

Radical cystectomy forms part of the treatment recommendations for patients with muscle-invasive tumors.

Learn more about treatment guidelines for urothelial carcinoma.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: